1. EP159/#428 Real-world experience and common adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer. (4th December 2022) Authors: Zammarrelli, William; Espino, Kevin; Yeoshoua, Effi; Ehmann, Sarah; Rubinstein, Maria; Green, Angela; Makker, Vicky Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lenalidomide in the treatment of Rosai Dorfman disease—a first in use report. Issue 2 (February 2016) Authors: Rubinstein, Maria; Assal, Amer; Scherba, Marina; Elman, Jordan; White, Robert; Verma, Amit; Strakhan, Marianna; Mohammadi, Farnoush; Janakiram, Murali Journal: American journal of hematology Issue: Volume 91:Issue 2(2016:Feb.) Page Start: E1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O017/#479 Germline pathogenic variants in DNA repair genes and endometrial cancer risk. (4th December 2022) Authors: Gordhandas, Sushmita; Rios-Doria, Eric; Cadoo, Karen; Catchings, Amanda; Maio, Anna; Kemel, Yelena; Manning-Geist, Beryl; Sia, Tiffany; Roche, Kara Long; Leitao, Mario; Mueller, Jennifer; Makker, Vicky; Rubinstein, Maria; Friedman, Claire; Ellenson, Lora; Birsoy, Ozge; Abu-Rustum, Nadeem; Aghajan... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗